deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02514070

Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Lipoprotein Metabolism PCSK9 Proteomics
Interventions DHA-rich fish oil EPA-rich fish oil
Updated 20 times since 2017 Last updated: Jun 25, 2021 Started: Oct 30, 2015 Primary completion: Jul 23, 2019 Completion: Jul 23, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Lipoprotein Metabolism and PCSK9, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 20 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Jan 2019 · 5 months · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~May 2019 · 2 months · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Dec 2019 · 2 months · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2022 · 15 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

20 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Sep 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 15 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE2

  2. Feb 2020 — Jan 2021 [monthly]

    Completed PHASE2

  3. Jan 2020 — Feb 2020 [monthly]

    Completed PHASE2

  4. Dec 2019 — Jan 2020 [monthly]

    Completed PHASE2

  5. Oct 2019 — Dec 2019 [monthly]

    Completed PHASE2

  6. Aug 2019 — Oct 2019 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

  7. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE2

  8. Jun 2019 — Jul 2019 [monthly]

    Recruiting PHASE2

  9. May 2019 — Jun 2019 [monthly]

    Recruiting PHASE2

  10. Mar 2019 — May 2019 [monthly]

    Recruiting PHASE2

  11. Jan 2019 — Mar 2019 [monthly]

    Recruiting PHASE2

  12. Aug 2018 — Jan 2019 [monthly]

    Recruiting PHASE2

  13. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE2

  14. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

  15. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

    First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations